Rate Video

EHA 2018 | Making CAR T-cells happen in Europe

John Gribben • 16 Jun 2018

EHA 2018

Chronic Lymphocytic Leukemia General Leukemia Lymphoma CAR-T

John Gribben, of Barts Cancer Institute, London, UK, discusses making CAR T-cells happen in Europe. This video was recorded at the 23rd congress of the European Hematology Association (EHA) 2018 press briefing, held in Stockholm, Sweden.

Lymphoma microenvironment: biology and therapy (part 3/3)

John Gribben et al. • 5 Sep 2014

The need for academic and pharmaceutical collaboration in drug development

Jay Bradner et al.

iwNHL 2015 roundtable: Day 2 highlights – ibrutinib for diffuse large B-cell lymphoma

John Gribben et al. • 3 Oct 2015

iwNHL 2015 roundtable: Day 2 highlights – PI3K inhibitors

John Gribben et al. • 3 Oct 2015

Related Videos

Patient perspectives of CAR T-cell therapy

Natacha Bolaños

Key challenges of using the intestinal microbiome as a biomarker

The multifaceted role of the advanced nurse practitioner

CAR T-cell therapy: the importance of LTFU